🐂 Not all bull runs are created equal. November’s AI picks include 5 stocks up +20% eachUnlock Stocks

Exponent shares target raised to $120 on strong outlook

EditorAhmed Abdulazez Abdulkadir
Published 26/07/2024, 11:24
EXPO
-

On Friday, Truist Securities adjusted its outlook on Exponent (NASDAQ:EXPO), a scientific and engineering consulting firm, by increasing the stock's price target to $120 from the previous $100, while maintaining a Buy rating. The decision follows Exponent's announcement of higher-than-expected third-quarter guidance and robust second-quarter performance, alongside an increased forecast for the full year.

The company experienced a 3% quarter-over-quarter decrease in technical full-time equivalents (FTEs), yet management remains focused on strategic hiring in areas of high demand. The firm reported a utilization rate of 75% for the quarter, a notable rise from 69% in the same quarter of the previous year. The projected average utilization rate for the entire year is expected to be around 72%.

Truist Securities also revised its earnings estimates for Exponent for the years 2024 and 2025, anticipating a steady improvement in demand. The updated price target reflects confidence in the company's future performance and its ability to sustain growth.

Exponent's increased full-year guidance and the positive outlook on demand are seen as key drivers for the raised price target. The consulting firm's focus on hiring in areas with high demand, despite a slight decline in technical staff, demonstrates its strategic approach to growth in a competitive market.

The new price target of $120 represents Truist Securities' expectation for Exponent's share value, supported by the company's solid quarterly results and optimistic guidance for the coming periods. Investors and stakeholders in Exponent can consider this updated analysis as they monitor the company's progress and financial health.

In other recent news, Exponent, Inc. reported a 14% increase in net income for the second quarter of 2024, indicating a strong financial stance despite moderated revenue growth. This growth was primarily driven by the company's reactive business, particularly in the sectors of transportation, utilities, and medical devices.

Based on these results, Exponent has uplifted its revenue and margin expectations for the year, showcasing confidence in its strategic initiatives and market position.

The company's earnings call also offered insights into financial projections, including stock-based compensation and operating expenses.

Projections indicate that stock-based compensation is expected to be between $5.2 million and $5.5 million for the current quarter, with interest income anticipated to be $2 million to $2.5 million per quarter.

The company also noted that no additional tax benefits from share-based awards are anticipated for the remainder of the year.

The company's focus on strategic recruitment and development for growth and profitability was also highlighted. In addition, Exponent's AI-related projects, especially in advanced driver assistance and medical devices, are gaining increased relevance.

The company is also working on improving algorithms and applications for medical devices and assisting utility clients in developing reliable decision models. These developments represent some of the recent activities of Exponent, Inc.

InvestingPro Insights

Following the positive outlook from Truist Securities on Exponent (NASDAQ:EXPO), InvestingPro data and tips offer additional insights into the company's financial health and market performance. Exponent boasts a strong balance sheet, holding more cash than debt, which is a reassuring indicator for investors concerned about financial stability. Additionally, the company's commitment to shareholder returns is evident, having raised its dividend for 11 consecutive years, a streak that reflects a reliable income stream for investors.

Key financial metrics from InvestingPro reveal a market capitalization of $5.37 billion, and while the company trades at a high earnings multiple with a P/E ratio of 53.38, this is in line with the industry standards for highly specialized consulting firms. The revenue growth over the last twelve months, as of Q1 2024, stands at 6.54%, demonstrating steady top-line expansion. Moreover, Exponent's return on assets of 16.95% underscores efficient use of its assets in generating earnings.

For investors seeking more in-depth analysis, there are additional InvestingPro Tips available, including insights on earnings revisions by analysts and stock volatility. To access these and other exclusive tips, visit: https://www.investing.com/pro/EXPO. Remember to use coupon code PRONEWS24 to get up to 10% off a yearly Pro and a yearly or biyearly Pro+ subscription. With these tools at your disposal, you'll be well-equipped to make informed investment decisions regarding Exponent.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.